Arcus Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | — | — | $65.2M |
| FY2017 | $36.6M | $190.5M | $98.4M |
| FY2018 | $40.0M | $274.9M | $71.1M |
| FY2019 | $39.3M | $203.1M | $57.9M |
| FY2020 | $270.0M | $772.3M | $173.4M |
| FY2021 | $750.4M | $1.59B | $148.0M |
| FY2022 | $688.0M | $1.35B | $206.0M |
| FY2023 | $633.0M | $1.10B | $127.0M |
| FY2024 | $665.0M | $1.15B | $150.0M |
| FY2025 | $508.0M | $1.14B | $222.0M |